{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Emma Reynish, Simona Hapca, Rebecca Walesby, Angela Pusram, Feifei Bu, Jennifer K Burton, Vera Cvoro, James Galloway, Henriette Ebbesen Laidlaw, Marion Latimer, Siobhan McDermott, Alasdair C Rutherford, Gordon Wilcock, Peter Donnan & Bruce Guthrie.

Emma Reynish ^1,*, Simona Hapca ², Rebecca Walesby ¹, Angela Pusram ¹, Feifei Bu ¹, Jennifer K Burton ³, Vera Cvoro ³, James Galloway ⁴, Henriette Ebbesen Laidlaw ¹, Marion Latimer ¹, Siobhan McDermott ¹, Alasdair C Rutherford ¹, Gordon Wilcock ⁵, Peter Donnan ², Bruce Guthrie ²

¹ Faculty of Social Sciences, University of Stirling, Stirling, UK
² School of Medicine, University of Dundee, Dundee, UK
³ Deanery of Clinical Sciences, University of Edinburgh, Edinburgh, UK
⁴ Health Informatics Centre, University of Dundee, Dundee, UK
⁵ Oxford Institute of Population Ageing, University of Oxford, Oxford, UK
^* Corresponding author Email: Emma.Reynish@stir.ac.uk

Declared competing interests of authors: Peter Donnan reports grants from Shire Pharmaceuticals Ltd (London, UK), Gilead Sciences, Inc. (Foster City, CA, USA) and Novo Nordisk (Bagsværd, Denmark) outside the submitted work, and that he is a member of the New Drugs Committee of the Scottish Medicines Consortium. Vera Cvoro reports receiving funded space from the European Stroke Organisation at the European Stroke Organisation Conference 2017, outside the submitted work.